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Abstract: The assessment of macrophage response to nanoparticles is a central component in 
the evaluation of new nanoparticle designs for future in vivo application. This work investigates 
which feature, nanoparticle size or charge, is more predictive of non-specific uptake of nano-
particles by macrophages. This was investigated by synthesizing a library of polymer-coated 
iron oxide micelles, spanning a range of 30–100 nm in diameter and −23 mV to +9 mV , and 
measuring internalization into macrophages in vitro. Nanoparticle size and charge both contrib-
uted towards non-specific uptake, but within the ranges investigated, size appears to be a more 
dominant predictor of uptake. Based on these results, a protease-responsive nanoparticle was 
synthesized, displaying a matrix metalloproteinase-9 (MMP-9)-cleavable polymeric corona. 
These nanoparticles are able to respond to MMP-9 activity through the shedding of 10–20 nm 
of hydrodynamic diameter. This MMP-9-triggered decrease in nanoparticle size also led to 
up to a six-fold decrease in nanoparticle internalization by macrophages and is observable by 
T2-weighted magnetic resonance imaging. These findings guide the design of imaging or thera-
peutic nanoparticles for in vivo targeting of macrophage activity in pathologic states.
Keywords: macrophage targeting, poly(ethylene glycol) (PEG), poly(propylene sulfide) (PPS), 
iron oxides, opsonization
Introduction
As one of the most phagocytic cells in the human body, macrophages are among 
the first cells of the innate immune system to arrive at a site of injury, but also have 
been observed as permanent residents in certain organs, such as in the liver and bone 
marrow.1–3 They function to clear pathogens and microbes, as well as host cell and 
matrix debris that are present at sites of tissue injury. Macrophages recognize and 
interact with this multitude of potential targets through a variety of mechanisms, includ-
ing phagocytosis and receptor-mediated endocytosis. The latter is mediated primarily 
through pattern recognition receptors, which include toll-like receptors, the mannose 
receptor (CD206), and scavenger receptor A (CD204).4–6 The polygamous nature of 
these pattern-recognition receptors is not restricted to natural ligands and targets. For 
example, CD204 has a wide range of molecular partners, leading to receptor-mediated 
endocytosis, distinct from the non-specific uptake due to pinocytosis.7 For the pur-
poses of this manuscript, we have defined this polygamous behavior as “non-specific” 
uptake or internalization. This is emphasized by evidence that CD204 has been shown 
to contribute to the non-specific uptake of nanoparticles surface-functionalized with 
carboxylic acids, antibodies, as well as synthetic polymers.8,9 Therefore, the rational 
design of nanoparticles for in vivo use requires an application-driven minimization 
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or optimization of such non-specific interactions between 
macrophages and synthetic nanoparticles. However, this area 
remains largely uninvestigated.
Non-specific interactions between macrophage receptors 
and nanoparticles may be dictated by a variety of charac-
teristics, including particle size, shape, surface charge, and 
hydrophobicity, and facilitated by surface chemistry-specific 
complement activation on the nanoparticle.10,11 Doshi and 
Mitragotri treated macrophages at 4°C with a library of 
polystyrene microparticles exhibiting a variety of sizes and 
shapes to mimic bacterial dimensions, and observed optimal 
attachment for rod-shaped particles with the longest dimen-
sion at 2–3 µm.11 However, the smallest particles investigated 
were in the range of 500 nm; work with such nanoparticles 
has yet to be extended to the sub-100 nm dimensional range, 
which is of interest in many in vivo applications. Raynal et al 
showed that macrophages exhibit size-dependent uptake of 
nanoparticles functionalized with dextran, but macrophages 
can interact directly with dextran, as their expression of a 
dextran receptor (SIGNR1) was later documented.12,13
Therefore, in this work, we sought to investigate non-
specific uptake of synthetic nanoparticles by macrophages, 
extending the work of these earlier groups into sub-100 nm 
PEGylated nanoparticles. To our knowledge, this is the first 
investigation of the effects of nanoparticle size, surface chem-
istry, and charge on non-specific uptake by macrophages. 
The rationale for using a PEG-functionalized nanoparticle 
system to accomplish these objectives is that macrophages 
are unlikely to have specific receptors for poly(ethylene 
  glycol) (PEG). Further, PEG can be easily modified to display 
various chemical functionalities, enabling the modulation of 
nanoparticle charge without significantly varying the bulk 
properties of the PEG coating. This is also a relevant model 
system for study because PEGylation of nanoparticles is com-
monly performed in order to render synthetic nanoparticles 
water-soluble and applicable for in vivo use. This is, in part, 
because PEG has been shown to discourage protein adsorp-
tion and opsonization on nanomaterial surfaces.14
Therefore, we used block copolymers of poly(ethylene 
glycol)-bl-poly(propylene sulfide) (PEG-PPS), which are 
amphiphilic copolymers that are capable of forming micelles 
and stabilizing hydrophobic drugs and nanoparticles at 
their liquid, PPS core.15,16 The incorporation of ultrasmall 
superparamagnetic iron oxides (USPIOs) into the micellar 
core of PEG-PPS block copolymers serves two functional 
purposes – enabling easy quantification of particle uptake 
through colorimetric assays, while also being a widely inves-
tigated contrast agent for T2-weighted magnetic resonance 
imaging (MRI). Through the use of a variety of materials 
processing techniques to form the micelles, including thin 
film hydration and direct hydration, the same starting PEG-
PPS copolymers and iron oxide cores can lead to monodis-
perse micelles (PEG-PPS-USPIOs) exhibiting hydrodynamic 
diameters at 30 nm, 40 nm, or 100 nm. Additionally, 
PEG-PPS-USPIOs can be fashioned with different surface 
chemistries at the PEG terminus, enabling an examination 
of charge-dependent non-specific uptake of nanoparticles 
by the macrophages.
To demonstrate the utility of these studies, we evaluated 
a protease-activity MRI probe design against these results. 
To make activity probes, PEG chains containing a protease-
cleavable peptide substrate were synthesized and conjugated 
to PPS, in order to fashion surfactants for the micellization 
of USPIOs. The resulting nanoparticles are “activatable” 
by protease activity through a $10 nm decrease in hydro-
dynamic diameter. Macrophages are therefore expected to 
internalize protease-treated nanoparticles differently than 
untreated nanoparticles. We hypothesize that these differ-
ences can be visualized via MRI with the aid of the contrast 
agent USPIOs encapsulated within the micelles. Taken 
together, the work presented here shows methods to design 
ideal nanoparticle dimensions and properties in order to better 
optimize nanoparticle behavior in vivo.
Materials and methods
All reagents were purchased from Sigma-Aldrich (St Louis, 
MO) and used as purchased unless otherwise noted below. 
Matrix metalloproteinase-9 (MMP-9), MMP-9 inhibitor, 
Fmoc-protected L-amino acids, and resins for solid-phase 
peptide synthesis were purchased from EMD Biosciences 
(Gibbstown, NJ). PEG reagents were purchased from Laysan 
Biosciences (Arab, AL). All dialysis supplies were ordered 
from Pierce Scientific (Rockford, IL) and used with modifi-
cations to the factory-provided protocol as indicated in the 
appropriate sections below. Copper transmission electron 
microscopy (TEM) grids with Formvar film and uranyl 
acetate were purchased from Electron Microscopy Sciences 
(Hatfield, PA). GIBCO® RPMI-1640 medium, penicillin-
streptomycin, and fetal bovine serum (FBS) were purchased 
from Life Technologies (Carlsbad, CA).
PEG-PPS block copolymers  
and functionalization
Synthesis of approximately 7 kDa carboxy-PEG-PPS 
(cPEG-PPS) was carried out as previously described.16 
For fluorescent polymers, FITC-PEG-NH2 was used 
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in place of cPEG-NH2 in the coupling reaction to PPS. 
The   MMP-9-cleavable peptide GGPRQITAGC (M9C; Gly-
Gly-Pro-Arg-Gln-Ile-Thr-Ala-Gly-Cys)17 was synthesized 
on a Rink-amide MBHA resin support, via standard Fmoc-
based solid phase peptide synthesis on an automated system 
(Protein Technologies PS3, Tucson, AZ).18 The peptide 
(1.5 eq, 45 mmol) was then reacted overnight with 1 eq of 
5 kDa methoxy-PEG-maleimide (mPEG-MAL; 30 mmol; 
150 mg), in an aqueous buffer containing 0.1 M Na3PO4 and 
0.15 M NaCl at pH 7.2. Unbound peptide was removed by 
dialysis across a 2 kDa molecular weight cutoff membrane 
overnight at room temperature. The completed mPEG-[M9C] 
conjugate was lyophilized, then coupled to cPEG-PPS via 
standard carbodiimide chemistry to yield mPEG-[M9C]-
PEG-PPS block copolymers.
For Fourier transform infrared (FT-IR) spectroscopy, 
polymer samples were prepared by mixing with IR-grade 
KBr and pelleting on a KBr press (Specac, Slough, UK). 
FT-IR was performed on a Bruker Tensor 27 system 
  (Billerica, MA).
Proton nuclear magnetic resonance (1H NMR) spectra 
were obtained at 400 MHz using a 9.4 Tesla Oxford magnet 
operated by a Bruker AV-400 console. The main NMR probe 
for the instrument is a 5 mm Z-gradient broadband inverse 
(BBI) probe with automatic tuning and matching capability 
(ATM).
Gel permeation chromatography (GPC) was performed 
on three resolving columns running in series (1 × TSKGel 
Alpha4000, 2 × TSKGel Alpha3000; Tosoh Bioscience, 
King of Prussia, PA) with dimethylformamide (DMF) + 0.1 
M LiBr mobile phase. Columns were incubated at 60°C, and 
chromatograms were obtained with a Shimadzu SPD-10A 
UV detector and RID-10A refractive index detector (Shi-
madzu Scientific Instruments, Columbia, MD), and a Wyatt 
miniDAWN Treos multi-angle light scattering detector 
(MALS; Wyatt Technology, Santa Barbara, CA). Data col-
lection and analysis was achieved through the Wyatt ASTRA 
software (v 5.3.4).
Encapsulation of USPIOs in PEG-PPS 
copolymers
Synthesis of hydrophobic, monodisperse USPIO core par-
ticles and their encapsulation in PEG-PPS copolymers was 
carried out as previously described.16 In brief, USPIO cores 
of predictable diameters were first synthesized through 
thermal decomposition, by controlling the molar ratios 
of iron precursor to oleic acid introduced in the reaction 
feed (Supplementary Figure S1). A 1:2 mass ratio of dried 
hydrophobic USPIO cores to PEG-PPS polymers were then 
dissolved in toluene, vortexed to mix, sonicated for 5 seconds 
to break apart clumps, and then dried by rotary evaporation 
for 20 minutes. The dried polymer/USPIO mixture was then 
rehydrated in 3 mL of nanopure water and vortexed vigor-
ously to suspend all particulates. Large clumps and byprod-
ucts were removed by magnetic pelleting, and the colloidal 
phase was collected and further centrifuged at 2500 g for 
5 minutes to precipitate excess polymers. The supernatant 
is gently aspirated by pipette into fresh scintillation vials 
and stored at 4°C.
To fabricate fluorescent micelles, a 1:40:20.5 mass ratio 
of FITC-PEG-PPS:PEG-PPS: iron oxide cores was mixed 
and micellized as described above. Therefore, the overall 
mass ratio of polymers to iron oxides is preserved at 1:2 for 
all micellization procedures. To make “proximity-activated” 
USPIOs (PA-USPIOs) – which are able to respond to local 
MMP-9 activity, OA-USPIOs were encapsulated in MMP-
9-cleavable mPEG-[M9C]-PEG-PPS polymers using the 
same protocol.
Pluronic®-PPS nanoparticles and loading 
with USPIOs
Pluronic-stabilized PPS nanoparticles (NPs) were synthe-
sized by inverse emulsion polymerization as described 
previously.10,19 Pluronic F-127 (a block copolymer of poly-
ethylene glycol and polypropylene glycol terminated by α 
and ω hydroxyl groups) was used alone or in combination 
with carboxyl-terminated Pluronic derivatized as previ-
ously described.20 The hydrophobic core was stabilized by 
disulfide crosslinking of the linear PPS chains.19 However, 
since crosslinking cannot reach completion, remaining free 
sulfhydryl groups on the NP surface were irreversibly capped 
by reaction with the alkylating reagent iodoacetamide. NP 
solutions were sterile-filtered, and then loaded with 3 nm 
USPIO cores through a direct hydration process. Then 
100 µL of the hydrophobic OA-USPIOs (20 mg/mL in tet-
rahydrofuran [THF]) was added to 1 mL of the Pluronic-PPS 
NPs (15 mg/mL in water) with swirling, and was followed 
by removal of THF by rotary evaporation, and removal of 
non-encapsulated OA-USPIOs by filtration through 0.45 µm 
Teflon filters (Whatman Inc, Piscataway, NJ).
Nanoparticle characterization
Size and ζ-potential of NPs were investigated by dynamic 
light scattering (DLS) in a Malvern Zetasizer Nano-ZS 
with the reusable dip-cell kit (Malvern Instruments Ltd, 
  Worcestershire, UK). For measurements of ζ-potential in 
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serum media, nanoparticles were mixed with THP-1 growth 
medium and allowed to incubate at 37°C for 24 hours prior to 
DLS measurements. No further purification of the nanopar-
ticles was performed. This is because the purification process 
ends up diluting the particles (along with the adsorbed pro-
teins), and may lead to further protein exchange interactions 
with media used downstream of isolation procedures, as per 
the Vroman effect.14 Therefore, in order to best mimic in vivo 
conditions, the nanoparticles were measured in the presence 
of serum. Measurements of hydrodynamic diameter demon-
strated the presence of a peak at ,5 nm that corresponded to 
proteins, while nanoparticles could still be easily discerned 
within the 20–100 nm diameter range.
Transmission electron microscopy (TEM) was conducted 
on a Philips CM20 system (Amsterdam, the Netherlands) 
operating at 200 kV . Carbon film-backed copper grids were 
inverted onto droplets containing nanoparticle suspensions 
of interest and blotted dry. Images were collected using a 
CCD camera with AMT Image Capture Engine software 
(v 600.335h built on 29 Apr 2010; Advanced Microscopy 
Techniques, Danvers, MA), and sizing of the particles was 
automated using a particle analyzer on ImageJ software 
(v 1.43u). Images were thresholded, and then the built-in 
(Analyze Particles) function was used to measure the major 
and minor axes of the fit ellipses around each particle. After 
artificially discarding clumps of particles encompassed within 
single fit ellipses (usually identified by major and minor axes 
that were .10% different from one another), or ellipses drawn 
around globs in the carbon grid (usually identified by any 
dimension ,1 nm), the diameter of individual particles was 
taken to be the average of the major and minor axis.
For aqueous samples, nanoparticles on TEM grids were 
also counterstained with 3% uranyl acetate in water for 
2 minutes, gently blotted dry, and dried in a vacuum desic-
cator for 2 hours prior to imaging.
Cell culture and nanoparticle  
co-incubation experiments
Non-adherent THP-1 human leukemic monocytes   (American 
Type Culture Collection, Manassas, VA) were grown in 
RPMI-1640 medium supplemented with 10% FBS, 1% 
penicillin-streptomycin, 1 × MEM vitamins (Mediatech, 
Manassas, VA), 120 µM β-mercaptoethanol, and 10 mM 
HEPES® (Sigma-Aldrich) at 37°C in a 5% CO2 incubator. 
For all cell experiments, monocytes were seeded into standard 
tissue culture-treated plates at a density of 300,000 cells/cm2, 
and differentiated for 3 days in growth medium (above) 
  supplemented with 200 nM of phorbol myristate acetate (PMA). 
The   differentiation   process leads to induction of cell   adherence 
onto tissue culture polystyrene surfaces.
For nanoparticle co-incubation experiments, cells were 
washed once with phosphate buffered saline (PBS) to remove 
unbound cells, prior to addition of growth medium. The 
medium was supplemented with nanoparticles and fucoidan. 
Nanoparticle dosing was based on total iron concentration 
as measured through the colorimetric phenanthroline assay 
as previously described.21 Final iron concentrations in the 
wells were calculated to be between 30 µM and 200 µM. For 
fucoidan competition experiments, media was supplemented 
with fucoidan to a final concentration of 0–500 µM.
At selected time points, cells were washed three times 
with PBS to remove unbound nanoparticles, and then lysed 
in 3 N HCl and 0.25% Triton X-100 for at least 2 hours. The 
strongly acidic environment also promotes solubilization of 
the endocytosed USPIOs via oxidation of the amphiphilic 
PEG-PPS shell on the nanoparticles into fully hydrophilic 
polymers,19 as well as leaching and mineralization of the 
iron in the USPIO core. The cell lysate was analyzed for 
protein content using a commercial Lowry protein assay kit 
(Bio-Rad Laboratories, Hercules, CA), while iron content 
was measured using the colorimetric phenanthroline assay 
as previously described.21 While the acidic conditions for the 
Lowry protein assay deviate significantly from the protocol 
described by the supplier (alkaline conditions), this does 
not significantly affect the sensitivity or results of the assay 
(Supplementary Figure S2).
Calculation of nanoparticle internalization was dependent 
upon nanoparticle type, as shown in Table 1. The rationale 
behind the two different measurement types is inherent to 
the loading efficiencies possible. Because PEG-PPS-USPIO 
samples are purified, all cell-nanoparticle interactions in 
experiments involving them involve an iron “tag”. However, 
since Pluronic-PPS-USPIOs are a subpopulation of the 
nanoparticles used in this system, not all cell-nanoparticle 
interactions here involve the iron tag. Due to differing USPIO 
loading efficiencies across the different Pluronic-PPS sur-
face chemistries available to us, an additional normalization 
method was required in order that resulting figures fully 
represented charge-dependent uptake of nanoparticles. The 
normalization of internalization data to the initially adminis-
tered dose of iron was therefore used to report internalization 
of Pluronic-PPS-USPIOs (Table 1).
For cell viability experiments, cells were incubated for 
24 hours with PEG-PPS-USPIOs, at a final iron dose of 
30 µM, 60 µM, or 120 µM. After rinsing cells three times 
with PBS to remove unbound nanoparticles, they were 
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Table 1 Quantification of nanoparticle uptake into THP-1 cells
Nanoparticle type Required measurements Units Equation Rationale
PEG-PPS-USPIOs [Fe] and [Protein]  
in cell lysates
µg Fe/mg protein [Fe]
[Protein]
result is a quantity normalized to cell number, 
but reflects dose-dependence and cell number-
dependence of quantified internalization
Pluronic-PPS-USPIOs [Fe] and [Protein] in 
cell lysates, and [Fe]0  
(concentration of iron  
administered at time 0)
%/mg protein [Fe]
[Fe]
100
[Protein]
0

 

  ×
Different surface chemistries led to differing 
loading efficiencies of Pluronic-PPS nanoparticles 
with USPIOs. Quantification method enables 
experiments to be run at constant nanoparticle 
concentrations, without worry of effects of different 
loading efficiencies on measured iron internalization 
Notes: PEG-PPS-USPIO internalization data was also represented as %ID/mg once in this manuscript (Figure 3E) in order to facilitate comparison of results.
Abbreviations: PEG, poly(ethylene glycol); PPS, poly(propylene sulfide); USPIO, ultrasmall superparamagnetic iron oxides.
stained with a commercial calcein-AM/ethidium homodimer 
live/dead assay kit (Invitrogen, Carlsbad, CA), and quantified 
according to the manufacturer’s instructions.
Protease-activatable nanoparticles
“Proximity-activated” USPIOs (PA-USPIOs) – which are 
able to respond to local MMP-9 activity, were formed as 
described for other PEG-PPS-USPIOs above. For pro-
tease experiments, 50 µL PA-USPIOs (iron dose = 600 µM) 
were incubated with 10 µL MMP-9 (final concentra-
tion = 2 µg/mL) in an aqueous buffer containing 0.1 M 
HEPES, 0.15 M NaCl, and 5 mM CaCl2 (pH 7.2) for 24 hours 
at 37°C. For control experiments, PA-USPIOs were incu-
bated with buffer only. Following cleavage, nanoparticles 
were added directly to cell cultures. The final concentra-
tion of iron and MMP-9 in the cell cultures were 120 µM 
and 400 ng/mL, respectively. In some control experiments, 
MMP-9 inhibitor was also added to the cell cultures, to a 
final concentration of 300 ng/mL.
Magnetic resonance imaging (MrI)
MRI was performed on a Varian 4.7 T horizontal bore 
imaging system. T2 signal decay was measured using a Carr-
Purcell-Meiboom-Gill (CPMG) spin-echo pulse sequence 
with N = 8 echoes with 6.5 ms echo spacing. The signal 
from each voxel at the eight imaging time points was fit to 
a mono-exponential signal decay model to determine T2 for 
each voxel:
  SS e
t
T =
−
0
2
  (1)
A region of interest (ROI) was manually drawn using 
MATLAB (MathWorks, Inc, Natick, MA) for the first 
imaging time point and translated to the images from later 
echoes. The mean T2 and standard deviation for each well 
was then calculated from all voxels within this ROI. Other 
imaging parameters included TR = 2 seconds, field of 
view = 22 mm × 22 mm, data matrix = 128 × 128, slice 
thickness = 1 mm, number of acquisitions = 24 (total scan 
time approximately 1 hour 45 minutes).
To prepare cells for MRI, the supernatant containing 
unbound nanoparticles in medium was aspirated and replaced 
with PBS, prior to scraping of the cells into the buffer 
  (Corning Life Sciences, Lowell, MA). Cells were centrifuged 
into a pellet at 300 g for 5 minutes, and rinsed with PBS twice 
more. Cells were then fixed with 10% buffered formalin, 
gently mixed, and allowed to incubate for 30 minutes at room 
temperature before they were pelleted and imaged.
Results and discussion
The primary objective of this study was to investigate size- 
and charge-dependent non-specific uptake of nanoparticles by 
macrophages. With the targeted size range being in the sub-
100 nm hydrodynamic diameter range, the objectives required 
the synthesis of a library of highly monodisperse, water-soluble 
nanoparticles in order to reduce size overlap between different 
nanoparticle formulations and elucidate trends between size 
and uptake. Therefore, USPIO cores were synthesized by ther-
mal decomposition in organic solvents, which led to oleic acid-
stabilized USPIOs (OA-USPIOs) of 3.0 ± 0.4 nm   (Figure 1A, 
n approximately 200) and 12.0 ± 1.0 nm   (Figure 1B, n . 400). 
Control over USPIO core diameters was accomplished by 
adjusting the molar ratios of oleic acid surfactant to iron 
pentacarbonyl precursor in the reaction feed, and to date, we 
have synthesized OA-USPIOs of up to 24 nm in diameter 
using this method (Supplementary Figure S1). These results 
extend previous work by Woo et al,22 who showed the ability 
to synthesize particles from 5 nm to 19 nm in diameter using 
this same exact method. Additionally, we were also able to 
scale up this original synthesis and now are able to produce 
the uniform OA-USPIOs in 1 g amounts.
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Figure 1 Characterization of USPIOs and PEG-PPS-USPIO micelles. HrTEM images of (A) 3 nm and (B) 12 nm hydrophobic, oleic acid-stabilized USPIO cores (γ-Fe2O3), 
which were synthesized via thermal decomposition. To render particles water-soluble, they were coated with PEG-PPS block copolymers via thin-film hydration to yield, 
respectively, (C) 30 nm and (D) 40 nm PEG-PPS-USPIO micelles. (E) 100 nm PEG-PPS-USPIO micelles can also be synthesized via direct hydration using the same feed 
materials used to create micelles in (D); this TEM image has been counterstained with 3% uranyl acetate. (F) Size-number distributions of these PEG-PPS-USPIO micelles 
were obtained by dynamic light scattering. (G) As shown in this representative photograph, 40 nm PEG-PPS-USPIOs remain stable in water and do not flocculate even 
after storage at room temperature over 4 months. 
Note: Scale bars: (A and C) 20 nm; (B and D) 100 nm; (E) 500 nm.
Abbreviations:  HRTEM,  high  resolution  transmission  electron  microscope;  PEG,  poly(ethylene  glycol);  PPS,  poly(propylene  sulfide);  TEM,  transmission  electron 
spectroscopy; USPIO, ultrasmall superparamagnetic iron oxides.
To render the OA-USPIOs water-soluble, either a thin-
film hydration or a direct hydration method was employed, 
effectively encapsulating OA-USPIOs within micelles com-
posed of amphiphilic PEG-PPS block copolymers (1.65 kDa 
PPS block, 4.2 kDa PEG block; Figure 1C–E). Prior to cell 
experiments, the micelles were sterile-filtered; size-number 
distributions of the completed USPIO-loaded micelles are 
shown in Figure 1F. However, due to the larger size of the 
100 nm micelles, these materials tended to be caught in the 
Teflon filters and were thus used as synthesized. The 30 nm 
and 40 nm micelles were particularly stable in water and 
flocculated minimally even after storage for several months 
at room temperature (Figure 1G). These two formulations 
were also extremely difficult to pellet by centrifugation or 
through the influence of an externally-applied 1 T neodymium 
magnet. The completed micelles exhibited ζ-potentials that 
were weakly anionic (Table 2), owing partly to the terminal 
mono-methyl ether group on the PEG block that is displayed 
on the nanoparticle surface.
Nanoparticles were next administered to THP-1 human 
leukemic macrophages in order to establish a quantitative basis 
for the remainder of the experiments, while also examining the 
kinetics of particle uptake. THP-1 cells were chosen for this 
study because uptake and processing of lipid   nanoparticles by 
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Table 2 Size and ζ-potential of as-synthesized PEG-PPS-USPIO 
micelles
Sample  
name
USPIO core  
diameter (nm)
Micelle diameter  
range (nm)a
ζ-potential  
(mV)
30 nm PEG- 
PPS-USPIOs
3 30.0 ± 2.6 −2.8 ± 5.9
40 nm PEG- 
PPS-USPIOs
12 36.6 ± 11.9 −1.7 ± 4.6
100 nm PEG- 
PPS-USPIOs
12 −7.8 ± 5.1
Notes: aDetermined after filtration through a 0.45 µm PTFE filter. 100 nm PEG-
PPS-USPIOs were not as stable to filtration and were not subjected to this additional 
treatment step prior to use in cell experiments.
Abbreviations: PEG, poly(ethylene glycol); PPS, poly(propylene sulfide); USPIO, 
ultrasmall superparamagnetic iron oxides.
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Figure 2 Dose- and size-dependent internalization of PEG-PPS-USPIOs by THP-1 macrophages. THP-1 cells were treated for up to 24 hours with standard growth serum 
medium supplemented with varying doses of PEG-PPS-USPIOs in PBS. As a negative control, PBS was used in place of the PEG-PPS-USPIO colloidal suspension. Iron internalization 
and initial doses were quantified using a colorimetric phenanthroline assay, and internalized iron content was normalized to cell number indirectly via a protein assay.   
(A) Internalization of nanoparticles over the time period of interest is described by first-order rate kinetics, indicating that initial dose of nanoparticles is the primary determinant 
of internalization rate and total internalization amount. relative to the initial doses of USPIOs, macrophages receiving 30 µM, 60 µM, and 120 µM of iron endocytosed 
8.4% ± 3.7%, 7.7% ± 3.2%, and 6.2% ± 0.9% of the maximum possible USPIOs, respectively. Error bars indicate standard deviations from six independent experiments.   
(B) Derivatives of the best-fit kinetic equations plotted in (A) demonstrate further the dependence of uptake rate on initial dose of PEG-PPS-USPIOs. (C) Of the three sizes 
investigated, 100 nm nanoparticles were most effectively internalized by the macrophages. Smaller nanoparticles were internalized less effectively, and 30 nm nanoparticles 
experienced almost negligible uptake levels over the 24 hour experimental period. Normalization of the 24 hour uptake amounts to the initially administered doses shows 
that macrophages internalized 6.2% ± 0.9%, 1.4% ± 2.3%, and 1.1% ± 0.3% of the 100 nm, 40 nm, and 30 nm PEG-PPS-USPIOs, respectively. Error bars represent standard 
deviation from three to six independent experiments. (D) Fluorescent imaging of the delivery of 40 nm and 100 nm fluorescent PEG-PPS-USPIO micelles. The uptake of 100 nm 
nanoparticles was easily visualized at 20× magnification with a 0.7 second exposure time, but even with a lower magnification and roughly a three-fold higher exposure time, 
the microscope was insufficiently sensitive to visualize the internalization of the 40 nm nanoparticles. (E) 40 nm PA-USPIOs (at 200 µM Fe) or 100 nm PEG-PPS-USPIOs (at 
120 µM Fe) were co-administered to THP-1 macrophages with varying amounts of fucoidan for 24 hours, and allowed to incubate overnight prior to cell lysis and measurement 
of internalized iron. Increasing concentrations of fucoidan correlated with decreased uptake of the nanoparticles, suggesting that the mechanism of PEG-PPS-USPIO uptake is 
via receptor-mediated endocytosis, and facilitated by the scavenger receptor CD204. Error bars represent standard deviation of three independent experiments.
Abbreviations: PA-USPIOs, proximity-activated ultrasmall superparamagnetic iron oxides; PBS, phosphate buffered saline; PEG, poly(ethylene glycol); PPS, poly(propylene 
sulfide); THP, human acute monocytic leukemia cell line.
THP-1 and primary human   monocyte-derived macrophages 
is not significantly different between the two cell types.23,24 
We expected, therefore, that macrophage interactions with 
synthetic nanoparticles can be similarly modeled through this 
readily available, in vitro system.
As an example, varying doses of the 100 nm PEG-PPS-
USPIOs were administered to THP-1 macrophages. Because 
first-order rate equations are often used as governing equa-
tions in efforts to model receptor-mediated endocytosis of 
nanoparticles by macrophages,25 the resulting 24-hour uptake 
profiles (Figure 2A) were fit to first-order rate kinetic equa-
tions (Figure 2A and B). The successful curve-fit suggested 
that USPIO concentration is the primary determinant of 
uptake rate. The best-fit equations take the form:
 [ C] = [C]max(1−e−kt)  (2)
where [C]max represents the maximum possible concentra-
tion of iron in the cells and [C] is a measure of the accu-
mulated iron content in the cells. As the fit equations show 
(Figure 2A), the calculated [C]max values are proportional 
to the initially administered doses of PEG-PPS-USPIOs 
(standard errors , 13%), while the calculated rate con-
stants k do not vary significantly across the doses (standard 
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errors 25%–40%). Relative to the initial doses of USPIOs, 
  macrophages receiving 30 µM, 60 µM, and 120 µM of iron 
endocytosed 8.4% ± 3.7%, 7.7% ± 3.2%, and 6.2% ± 0.9% 
of the maximum possible USPIOs, respectively. In order 
to ensure that the measurements excluded USPIO binding 
events not resulting in uptake, some experiments were also 
conducted at 4°C to block endocytosis, resulting in insig-
nificant iron levels quantified in the lysates (Supplementary 
Figure S3). In addition, a live/dead cytotoxicity assay was 
also conducted in order to confirm that treatment of mac-
rophages with the PEG-PPS-USPIOs resulted in minimal 
cell death (Supplementary Figure S4).
Similar nanoparticle uptake kinetics were also observed 
for particles of smaller hydrodynamic diameters (Figure 2C). 
The results also show that by mass, smaller nanoparticles are 
internalized less effectively than their larger counterparts. 
The 40 nm nanoparticles shown in this graph were based on 
a higher iron dose for easier visualization; however, the same 
nanoparticles, administered at the same 120 µM Fe dose as 
the other two samples, were internalized at 0.36 ± 0.55 µg/mg 
protein (curve not shown). Normalization of the 24-hour 
uptake data to the initially administered doses shows that 
THP-1 macrophages were able to internalize 1.1% ± 0.3%, 
1.4% ± 2.3%, and 6.2% ± 0.9% of the 30 nm, 40 nm, and 
100 nm PEG-PPS-USPIOs, respectively. When nanoparticle 
internalization is normalized to cell number, a 70% decrease 
in PEG-PPS-USPIO diameter corresponded with almost a 
ten-fold decrease in iron uptake per cell. This was supported 
by fluorescence microscopy experiments, where macrophages 
were treated with FITC-tagged nanoparticles (Figure 2D), 
demonstrating the accumulation of 100 nm micelles within 
the macrophages. Despite longer exposure times at a lower 
magnification, the microscope was insufficiently sensitive 
to visualize the internalization of the 40 nm micelles by the 
macrophages. Taken together, these data suggest a positive 
correlation between nanoparticle size and their non-specific 
recognition and internalization by macrophages.
Given the lack of any specific targeting moieties on the 
micelle surface, this evidence suggested that within the 
nanoparticle size range investigated, macrophages were able 
to optimally recognize and internalize PEGylated nanopar-
ticles of .100 nm diameter. Further, smaller nanoparticles 
seemed to experience significantly less non-specific uptake 
by the macrophages. One of the mechanisms of uptake is 
likely through receptor-mediated endocytosis via CD204 – as 
PEG-PPS-USPIO internalization can be effectively blocked 
by co-administration of nanoparticles with fucoidan, which 
is a well-known CD204 ligand (Figure 2E).4
We next investigated the effects of nanoparticle charge 
on non-specific uptake. Because the sub-40 nm nanopar-
ticles provided a satisfactorily minimal baseline uptake over 
24 hours, we opted to focus on nanoparticles of this size 
for this section of the study. End-carboxylated, -aminated, 
and -thiolated Pluronic were used as surfactants in inverse 
emulsion polymerization as described previously.10 The 
resulting Pluronic-PPS nanoparticles were loaded with 
USPIOs via direct hydration (Figure 3A–C), and delivered 
to THP-1 macrophages under the same conditions described 
for the other cell experiments above. Since Pluronic polymers 
are PEG-containing block co-polymers, the properties of 
Pluronic-PPS are not very different from those of PEG-PPS 
used in the other studies shown here, and, in effect, still pro-
duce PEG-PPS-coated USPIOs. Pluronic-PPS enables facile 
synthesis schemes necessary to produce the various end-
functionalized polymers used in this work that would other-
wise be more difficult to generate from PEG-PPS coatings.19
In order to account for differences in USPIO loading 
efficiencies across the library of Pluronic-PPS nanoparticle 
formulations, uptake was not only reported as [Fe]/[Protein] 
as above, but further normalized to initial doses of iron and 
reported as percent injected dose/protein (%ID/mg protein; 
Figure 3D, Table 1). We hypothesized that this system would 
enable us to parse out the roles of surface charge from size 
on nanoparticle internalization, leading us to identify the 
sensitivity of size and charge on nanoparticle non-specific 
uptake by macrophages.
The Pluronic-PPS-USPIOs initially exhibited surface 
charges from −23 mV up to +9 mV , but following incubation 
in 10% serum media for 4 hours, all nanoparticle formulations 
experienced significant changes in ζ potential (Figure 3D). 
Therefore, while the ζ potential of the nanoparticles was 
tunable to some extent by varying the surface chemistry 
of the nanoparticles, electrostatic interactions with serum 
proteins and components, as well as protein adsorption and 
opsonization processes contributed to significant changes in 
nanoparticle properties. The addition of serum into the incu-
bation medium for these studies is intended to reflect an 
interaction environment that includes important components 
of the in vivo environment. Since there is no opportunity for 
nanoparticle purification following intravenous injection, we 
elected to allow nanoparticle interaction with serum proteins 
during ζ potential measurements, and later on, incubation 
with THP-1 cells. One outcome of this approach, and equally 
true in vivo, is the modulation of initial nanoparticle ζ poten-
tial by serum protein adsorption. These processes have been 
studied in detail for the Pluronic-PPS nanoparticle   system, as 
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agglomeration, as no flocculation or sedimentation was 
observed in any of the samples following treatment with 
serum. This observation was true of all nanoparticle formula-
tions regardless of surface chemistry, possibly owing to the 
colloidal stability of Pluronic-PPS nanoparticles as shown 
previously.19
The two formulations that were most efficiently inter-
nalized were the nanoparticles displaying the terminal 
OH (12% ± 5% ID/mg protein) and the 10%COOH/90% 
OH/SH (11% ± 5%/mg). Uptake correlated with nano-
particle charge as measured in serum, yielding a parabolic 
trend with maximum uptake observed for cationic and 
strongly anionic nanoparticles (Figure 3D, R2 = 0.94, inset). 
However, because interactions with serum compressed 
the range of nanoparticle ζ potentials, we were unable to 
experimentally explore uptake of the nanoparticles beyond 
the −10 mV to 0 mV range. Despite the narrow window 
of ζ potentials covered by the data, the trends suggest that 
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Figure 3 Effects of nanoparticle surface charge and chemistry on macrophage uptake. representative TEM images of (A) hydrophobic, unloaded 3 nm OA-USPIOs and 
(B) water-soluble Pluronic-PPS nanoparticles after loading with the OA-USPIOs. (C) The loading process does not significantly affect the hydrodynamic diameters or the 
ζ potentials inherent to the Pluronic-PPS nanoparticles. (D) ζ-potential of all nanoparticle formulations (color-coded by surface chemistry) was originally measured in 
PBS following synthesis, and again following incubation in 10% serum media. While modulation of surface chemistry allows for a wide range of ζ-potentials, this range is 
compressed due to interactions between nanoparticles and media components. Uptake of nanoparticles correlated with their surface charge as measured in media (inset; red 
dotted boxes indicate source of data for x-axis), according to a parabolic distribution. To account for differences in USPIO loading efficiency across the different Pluronic-
PPS nanoparticle formulations, nanoparticle uptake was normalized to the initial dose administered as well as cell content indirectly, via a protein assay. Error bars indicate 
standard deviation for three independent experiments. (E) Cell internalization data is plotted versus nanoparticle ζ-potentials measured in 10% serum media (solid squares). 
In order to determine which nanoparticle feature may be more determinant of non-specific interactions with macrophages, the effects of nanoparticle diameter have also 
been plotted for comparison (open squares).
Abbreviations: OA-USPIOs, oleic acid-stabilized ultrasmall superparamagnetic iron oxides; PBS, phosphate buffered saline; PPS, poly(propylene sulfide); TEM, transmission 
electron microscopy.
reported by Thomas et al.10 In particular, varying the surface 
chemistry of this nanoparticle system influenced the ability 
of the nanoparticles to become functionalized with the C3 
  complement proteins.10 More generally, this phenomena is well 
known in the synthetic gene delivery field, in which cationic 
nanoscale carriers of pDNA or siRNA rapidly interact with 
albumin and other serum proteins in vivo, and is consistent 
with the findings reported here.26 This is significant because 
many consider that a minimum ζ potential of ±30 mV is 
necessary in order to form stable nanoparticle suspen-
sions.27 Because electrostatic interactions and adsorption 
processes between serum proteins and the nanoparticle 
surface are inevitable following in vivo administration, 
higher ζ potential magnitudes may actually promote these 
processes, and in turn, opsonization processes ultimately 
leading to nanoparticle clearance from the bloodstream.
The observed decrease in the magnitude of the nano-
particle ζ potentials did not correspond with increased 
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non-specific uptake of nanoparticles may be promoted by 
nanoparticle cationicity or high anionicity. This is consistent 
with previous observations.13
Uptake of nanoparticles in serum was minimized in the 
range of ζ potentials from −9.0 mV to −3.5 mV . A three-
fold increase in uptake was measured for identically sized 
nanoparticles having ζ potentials in serum from −3.5 mV 
to −0.8 mV , representing a 77% decrease in anionicity. In 
comparison, a four-fold change in uptake was observed 
for a 60% decrease in PEG-PPS-USPIO diameter (100 nm 
to 40 nm). Over these ranges and conditions, macrophage 
uptake of these nanoparticles is 42% more sensitive to size 
than to ζ potential (Figure 3E).
To expand on this conclusion, we synthesized PEG-PPS-
USPIOs containing an MMP-9-degradable peptide (M9C) 
within the PEG chain (Figure 4A and B). This design results 
in particles that respond to active MMP-9 in the environ-
ment by releasing a layer of PEG, effectively leading to 
a decrease in nanoparticle diameter. Probes for MMP-9 
activity are of wide interest because of the upregulation 
of MMP-9 in the progression of atherosclerosis.28–30 Based 
on the studies described earlier, we hypothesized that this 
experimental contrast agent would experience less uptake 
by macrophages following treatment with MMP-9, relative 
to the as-synthesized, intact form.
These MMP-9-responsive contrast agents were synthe-
sized by encapsulating 10 nm and 3 nm OA-USPIOs using 
approximately 10 kDa mPEG-[M9C]-PEG-PPS (subse-
quently referred to as “PA” for protease-activatable), to pro-
duce 60 nm and 30 nm PA-USPIOs (Figure 4C and D). Both 
PA-USPIO formulations responded to MMP-9 treatment 
with a 10–20 nm decrease in nanoparticle hydrodynamic 
diameters as measured by DLS, while ζ-potentials were not 
significantly affected (30 nm PA-USPIOs: −3.9 ± 6.4 mV 
pre-cleavage, −2.8 ± 5.9 mV post-cleavage; 60 nm PA-
USPIOs: 0.0 ± 7.1 mV pre-cleavage, −4.7 ± 5.5 mV post-
cleavage). For cell experiments, PA-USPIOs were incubated 
with MMP-9 for 24 hours prior to their administration to 
THP-1 cells at equivalent iron doses. In both cases, MMP-
9-treated PA-USPIOs were internalized significantly less 
effectively than their non-cleaved counterparts (Figure 4E). 
Most notably, the 30 nm PA-USPIOs experienced a six-
fold decrease in nanoparticle uptake following MMP-9 
cleavage (0.12 ± 0.04 µg Fe/mg protein pre-cleavage vs 
0.02 ± 0.02 µg/mg post-cleavage). Also of note is the slightly 
higher uptake of the MMP-9-treated 60 nm PA-USPIOs (final 
diameter = 40.0 ± 6.2 nm) relative to the untreated 30 nm 
PA-USPIOs (30.0 ± 2.6 nm).
Because these changes in nanoparticle internalization 
may be due to MMP-9-mediated modifications on the 
cell membranes, a series of control experiments were also 
performed, using non-cleavable, 40 nm   PEG-PPS-USPIOs 
  (Supplementary Figure S5). In these experiments, 
  co-administration of non-cleavable nanoparticles with 
MMP-9 did not lead to significant differences in nano-
particle internalization. Further, co-administration with a 
MMP-9 inhibitor also did not affect internalization. Taken 
together, the results suggest that the variations in PA-USPIO 
internalization by the THP-1 cells were attributable to the 
size of the nanoparticles, as the nanoparticle ζ potentials 
did not vary significantly before versus after treatment with 
MMP-9. Further, cellular capacity for nanoparticle internal-
ization was unaffected by exposure to protease.
To determine if these MMP-9-dependent differences in 
nanoparticle internalization result in statistically significant 
changes in sample T2 relaxation, and therefore, clinically 
relevant detection of MMP-9 activity in cell samples, 60 nm 
PA-USPIO-treated cells were pelleted and imaged on a 
4.7 T magnetic resonance imaging scanner (Figure 4F). 
Through the use of a CPMG spin-echo pulse sequence, 
MMP-9-treated PA-USPIOs appeared to exhibit higher 
mean gray intensities versus cells incubated with untreated 
PA-USPIOs.
While the PA-USPIOs exhibited T2 = 4.82 ± 0.02 ms, the 
PA-USPIOs on the macrophages exhibited T2 = 23.2 ± 3.5 ms. 
These rather strong changes in T2 are somewhat surprising 
assuming that approximately 1% of the administered dose 
was taken up by the macrophages as measured in the earlier 
sections of this work. This implies that for each imaging 
slice, the concentration of iron responsible for T2 signal 
modulation within that slice is about 100-fold less in the 
nanoparticle-treated cell samples versus the positive control. 
To quantify this phenomenon, the calculated values above 
(from first-principle measurements) can be plugged into the 
R2 relaxivity equation:
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in order to produce a measure of how effective the USPIOs 
are in modulating the local negative contrast. Given that 
measured T2 in the cell samples is only approximately five 
times higher than the measurements in the positive control, 
the iron concentration in the cell samples would need to be 
about a fifth of the concentration in the positive control in 
order to maintain the same R2 value. As we have seen, this 
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Figure 4 Behavior of MMP-9-responsive PA-USPIOs. (A) Synthesis of MMP-9-cleavable PEG-PPS chains (mPEG-[M9C]-PEG-PPS; PA) and (B) encapsulation of USPIOs to 
form PA-USPIOs. MMP-9 is able to recognize and cleave the (M9C) peptide sequence, resulting in release of a layer of PEG from the nanoparticle surface, accompanied by 
a decrease in nanoparticle hydrodynamic diameter. (C) DLS characterization of hydrodynamic diameters of as-synthesized 60 nm PA-USPIOs (C; green) and 30 nm PA-
USPIOs (D; blue) demonstrates a loss in hydrodynamic diameter following treatment with MMP-9. (E) Buffer-treated or MMP-9-pretreated nanoparticles were delivered to 
THP-1 macrophages for 24 hours in standard growth medium. As a control, PBS was used in place of the nanoparticles. For both PA-USPIO formulations tested, the decrease 
in nanoparticle size following MMP-9 treatment results in less effective nanoparticle internalization by the macrophages. Error bars represent standard deviations from three 
to six independent experiments. (F) T2-weighted MrI of THP-1 cells treated with MMP-9-cleaved PA-USPIOs appeared brighter than cells incubated with untreated PA-
USPIOs, indicating that less cleaved nanoparticles were internalized by the macrophages versus the untreated PA-USPIOs.
Note: *P , 0.05 by Student’s t-test.
Abbreviations: DLS, dynamic light scattering; MMP-9, matrix metalloproteinase-9; PA-USPIOs, proximity-activated ultrasmall superparamagnetic iron oxides; MrI, magnetic 
resonance imagery; PBS, phosphate buffered saline; PEG, poly(ethylene glycol); PPS, poly(propylene sulfide).
is hardly the case, and based on our data, we can conclude 
that the R2 values in the cell sample would have to be on 
the order of 20-fold larger than the R2 of the free-floating 
PA-USPIOs. These results indicate that following inter-
nalization by the macrophages, the PA-USPIOs are being 
manipulated in such a way that increases their ability to 
exert T2 contrast.
This phenomenon can be explained by previous obser-
vations that aggregated or clustered superparamagnetic 
nanoparticles result in higher R2 versus fully dispersed, 
singlet nanoparticles.16,31 Others have demonstrated via 
TEM that following endocytosis of iron oxide nanoparticles, 
macrophages can process the particles into lysosomes, 
where dense clusters of particles can usually be observed.32 
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Taken together, these other observations help explain how 
even a small amount of nanoparticle uptake results in a 
marked change in T2 contrast in the system.
Conclusion
PEGylated nanoparticles are internalized by macrophages in 
a size-dependent fashion for diameters between 30 nm and 
100 nm. Charge-uptake relationships were investigated by 
varying the surface properties of nanoparticles. While the 
data supports the possibility that cationic and strongly anionic 
nanoparticles may be internalized most effectively, within 
the ranges investigated, nanoparticle size, not charge, is a 
stronger determinant of non-specific uptake by   macrophages. 
Based on this information, an MMP-9-sensitive nanoparticle 
was developed that decreases in size following treatment with 
MMP-9. Macrophages respond to MMP-9-treated nanopar-
ticles in a predictable fashion, and cleaved nanoparticles 
were consistently phagocytosed less efficiently than their 
untreated counterparts, demonstrating the effects of dynamic 
nanoparticle size modulation on macrophage uptake. These 
MMP-9-induced differences in uptake are also detectable 
via MRI. Despite the low levels of overall uptake over the 
24 hour incubation periods (#1% initially administered 
dose), a significant increase in macrophage R2 was observed. 
Presumably, and consistent with quantitative analysis, the 
clustering of nanoparticles into endosomes following endo-
cytosis results in an increase in nanoparticle R2, providing 
amplification of negative MR image contrast. The results 
presented here inform the design of nanoparticles to target 
or evade macrophages in future in vivo applications.
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Supplementary figures
Online supplementary materials include the following 
Figures: (S1) control over iron oxide nanoparticle size, (S2) 
Lowry protein assay standard curves, (S3) nanoparticle 
  binding experiments, (S4) nanoparticle cytotoxicity assay, and 
(S5) control internalization experiments involving MMP-9, 
MMP-9 inhibitor, and protease-insensitive nanoparticles.
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Figure S2 Lowry protein assay standard curves. BSA was dissolved in PBS and treated with either 0.1 N NaOH or 6 N HCl prior to performance of the Lowry protein assay. 
While the assay is typically run under alkaline conditions (blue), strong acidic conditions do not significantly affect the sensitivity or reliability of this assay.
Abbreviations: BSA, bovine serum albumin; PBS, phosphate buffered saline.
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Figure S3 Twenty-four hour uptake of nanoparticles by THP-1 macrophages. Cells 
were treated with 40 nm PEG-PPS-USPIOs for 24 hours, and then measured for iron 
content via the phenanthroline assay. Iron content was normalized to cell number 
indirectly via a protein assay. To confirm that the phenanthroline assay measures 
internalized nanoparticles and not just nanoparticles that have bound to macrophage 
receptors, some cells were incubated with nanoparticles at 4°C. results showed 
about ten-fold lower iron content in these samples relative to samples treated at 
37°C, indicating that the protocol successfully lyses cells and enables measurements 
of internalized iron. 
Note: Error bars indicate standard deviation of three independent experiments 
(*P , 0.01).
Abbreviations: PEG, poly(ethylene glycol); PPS, poly(propylene sulfide); USPIO, 
ultrasmall superparamagnetic iron oxides; THP, human acute monocytic leukemia 
cell line.
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Figure S1 Feed ratio of oleic acid surfactant to iron pentacarbonyl precursors 
and resulting USPIO diameters. A 6 mmol quantity of Fe(CO)5 was introduced into 
reactors containing 40 mL octyl ether and varying amounts of oleic acid at 100°C. 
USPIO cores were allowed to grow and then oxidize as described in materials and 
methods, and then imaged by HrTEM. Core diameters were measured via ImageJ 
software.
Abbreviations:  HrTEM,  high  resolution  transmission  electron  microscope; 
USPIO, ultrasmall superparamagnetic iron oxides.
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Figure  S4  Cell  viability  measurements  on  nanoparticle-treated  THP-1  cells, 
normalized to untreated cells (media + PBS). Cells were treated with increasing 
doses of 100 nm PEG-PPS-USPIOs for 24 hours, prior to removal of unbound 
nanoparticles and assessment of cell viability via quantification of calcein-AM/ethidium 
homodimer staining. Dosage on the x-axis represents actual iron concentration 
within the samples. No statistically significant differences in viability were observed 
between any of the treatment groups (n = 3).
Abbreviations:  PBS,  phosphate  buffered  saline;  PEG,  poly(ethylene  glycol);   
PPS,  poly(propylene  sulfide);  USPIO,  ultrasmall  superparamagnetic  iron  oxides;   
THP, human acute monocytic leukemia cell line.
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Figure S5 Co-administration of 40 nm PEG-PPS-USPIOs (do not contain MMP-
9-cleavable  peptide)  with  MMP-9  does  not  significantly  affect  internalization  of 
nanoparticles. THP-1 cells were treated with media only (untreated), nanoparticles 
only, or nanoparticles co-administered with 200 ng/mL MMP-9 and/or 300 ng/mL 
MMP-9  inhibitor.  Because  these  nanoparticles  do  not  contain  MMP-9-cleavable 
elements,  their  diameter  is  unaffected  by  treatment  (data  not  shown).  MMP-9 
treatment does not change the properties of the THP-1 cell membrane in a way that 
affects their interactions with nanoparticles. Error bars indicate standard deviation 
for three independent experiments.
Abbreviations: MMP-9, matrix metalloproteinase-9; PEG, poly(ethylene glycol); 
PPS,  poly(propylene  sulfide);  USPIO,  ultrasmall  superparamagnetic  iron  oxides;   
THP, human acute monocytic leukemia cell line.
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